Conclusions:
Among selected subjects with COPD, azithromycin taken daily for 1 year, when added to usual treatment, decreased the frequency of exacerbations and improved quality of life but caused hearing decrements in a small percentage of subjects. Although this intervention could change microbial resistance patterns, the effect of this change is not known. (Funded by the National Institutes of Health; ClinicalTrials.gov number, NCT00325897.).
1st LINK
2nd LINK
Archive for October, 2011
Azithromycin for prevention of exacerbations of COPD by 25%?
Author: adminOct 17
Dr. Tummy: Resource for Kids and Parents
Author: adminOct 10
